1. Carl Zeiss Meditec

    0 Comments Leave a Comment

    1-15 of 1939 1 2 3 4 ... 128 129 130 »
    1. Mentioned In 1939 Articles

    2. Analysis of Peripapillary Intrachoroidal Cavitation and Myopic Peripapillary Distortions in Polar Regions by Optical Coherence Tomography

      Analysis of Peripapillary Intrachoroidal Cavitation and Myopic Peripapillary Distortions in Polar Regions by Optical Coherence Tomography
      ... in both eyes of the subjects. Color fundus pictures were taken using a VISUCAM® non-mydriatic camera (PRO NM Carl Zeiss Meditec, Jena, Germany) and Spectral Domain OCT imaging using Spectralis® HRA-OCT (Heidelberg Engin...
      Read Full Article
    3. Reproducibility of Neuroretinal Rim Measurements Obtained from High-Density Spectral Domain Optical Coherence Tomography Volume Scans

      Reproducibility of Neuroretinal Rim Measurements Obtained from High-Density Spectral Domain Optical Coherence Tomography Volume Scans
      ...isual field (VF) testing (Swedish Interactive Threshold Algorithm 24–2 test of the Humphrey VF analyzer 750i; Carl Zeiss Meditec, Dublin, California), and optical coherence tomography (OCT) scans (Spectralis HRA+OCT, Hei...
      Read Full Article
    4. Evaluating the Quantitative Foveal Avascular Zone and Retino-Choroidal Vessel Density Using Optical Coherence Tomography Angiography in a Healthy Indian Population

      Evaluating the Quantitative Foveal Avascular Zone and Retino-Choroidal Vessel Density Using Optical Coherence Tomography Angiography in a Healthy Indian Population
      ..., Germany), 105.47±1.51 with DRI OCT-1 Atlantis (Topcon Medical Systems, Inc., Oakland, NJ), 94.67±11.29 with Zeiss AngioPlex, and 88.75±10.54 with Spectralis OCTA (Heidelberg Engineering, Germany) [27]. This shows that ...
      Read Full Article
    5. Personalized treatment supported by automated quantitative fluid analysis in active neovascular age-related macular degeneration (nAMD)—a phase III, prospective, multicentre, randomized study: design and methods

      Personalized treatment supported by automated quantitative fluid analysis in active neovascular age-related macular degeneration (nAMD)—a phase III, prospective, multicentre, randomized study: design and methods
      ...iss Meditec, Inc., Dublin, CA, USA)), colour fundus photography and additionally OCTA-Scans (PLEX Elite 9000, Carl Zeiss Meditec, Inc., Dublin, CA, USA) if available. Blue-peak blue-laser autofluorescence (BAF), infrared...
      Read Full Article
    6. Technology Partnership Delivers for Sydney Eye Hospital

      Technology Partnership Delivers for Sydney Eye Hospital
      Since the installation of the microscope in Sydney Eye Hospital, the surgical faculty has been quick to take advantage of this new equipment, helping them undertake innovative and pioneering surgical procedures across a variety of glaucoma, cataract, corneal and retinal pathologies. The combination of the digital optics and digital cockpit offered by the Artevo 800 allows surgeons and theatre staff to view a three-dimensional image of the ophthalmic procedures on ...
      Read Full Article
    7. Agreement of intraocular lens power calculation between 2 SS-OCT–based biometers

      Agreement of intraocular lens power calculation between 2 SS-OCT–based biometers
      Purpose: To assess agreement of measurements by 2 swept-source optical coherence tomography biometers and to evaluate the prediction error (PE) in intraocular lens power calculation with 7 formulas. Setting: Tertiary public eye hospital. Design: Consecutive observational. Methods: Axial length (AL), keratometry (K), anterior chamber depth (ACD), lens thickness (LT), and corneal diameter (CD) were measured with the IOLMaster 700 (Biometer A) and Anterion (Biometer B). Agreement was quantified by the ...
      Read Full Article
    8. Effect of Light Conditions and Accommodation on Implantable Phakic Contact Lens Vault by Anterior Segment Optical Coherence Tomography

      Effect of Light Conditions and Accommodation on Implantable Phakic Contact Lens Vault by Anterior Segment Optical Coherence Tomography
      ... The size of the IPCL was selected according to the ACD and horizontal white to white (WTW) using IOL Master (Carl Zeiss Meditec, Jena, Germany). All patients were examined 1 month or more after surgery (not before 1 mon...
      Read Full Article
    9. 1-15 of 1939 1 2 3 4 ... 128 129 130 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. About Carl Zeiss Meditec

    Carl Zeiss Meditec

    Carl Zeiss Meditec.  Ophthalmology Systems.  Carl Zeiss Meditec is an integrated medical technology company with two main areas of business activity.  In the field of ophthalmology we offer complete solutions for treating the four main eye ailments: vision defects (refraction), cataract, glaucoma and retinal disorders. Our products support doctors and patients to diagnose and treat these ailments efficiently and precisely, thus giving both of them clear benefits, not least by offering them a comprehensive disease management solution. The acquisition of Carl Zeiss Surgical has strengthened our leading market and competitive position for devices and systems in ophthalmic surgery.  Furthermore, we have secured an outstanding starting position in the growth market of neuro/ENT surgery. As the world‘s leading provider of surgical microscopes and visualisation solutions for these treatments, we will further expand our footprint in this area through organic growth and strategic expansion into adjacent market segments. In doing so, we want to develop into a solution provider in this area as well.  Carl Zeiss Meditec's medical technology portfolio is rounded off by innovative and promising future technologies such as intraoperative radiation therapy, which allows the targeted treatment of breast cancer and brain cancer during the operation stage itself.

  3. Quotes about Carl Zeiss Meditec

    1. I have come to rely on the Carl Zeiss Meditec brand for consistent and reliable technologies that are at the forefront of innovation and patient care.
      In Carl Zeiss Meditec Introduces New Suite of Ophthalmic Innovations
    2. Mr Taylor has been instrumental in making Meditec one of the leading companies in the field of ophthalmology in the past few years. My sincere thanks are due to him for his effort and dedication. I am pleased that Mr Taylor will continue to support us in the role of independent consultant and that we will be able to draw on his experience in future. Furthermore, I am convinced that we are ideally set with our current team to accelerate the proposed realisation of growth potential of Carl Zeiss Meditec.
      In Carl Zeiss Meditec reorganises management of its strategic business units
    3. Carl Zeiss Meditec received the highest overall Frost & Sullivan Competitive Metrics Score in the recently completed Strategic Analysis of Optical Imaging Technologies in U.S. Clinical Diagnostics Markets.
      In Frost & Sullivan Lauds Carl Zeiss Meditec for Dominating the OCT Market for Ophthalmic Applications